This James Lind Alliance survey will inform research priorities for liver cirrhosis for the next decade.
Get involved:
The survey is a collaboration between the UK-CLIF Network, the James Lind Alliance, and the British Liver Trust.
Find out more here.
Our mission is to improve outcomes for patients with decompensated cirrhosis, through the developments of new treatments, improving access to clinical trials, and raising the profile of liver disease in the UK.
We have representatives from all areas across the UK including patients, carers, doctors, scientists, nurses, and other healthcare professionals.
Would anyone be happy to say they are offering ‘gold standard’ care all of the time? Does every patient around the country have the same access to tips, transplant or even second line agents for conditions like pbc or clinical trials? @BSGTrainees @BASLedu @LiverTrust @UK_CLIF https://t.co/Q0BES60HwU
— Oliver Tavabie (@OTavabie) March 18, 2024
Looking forward to this - a lot to think about and discuss! @DebbieShawcros1 @JasmohanBajaj @DrLChina @AleksanderKrag @MajaThiele @CholestasisDoc @NadirAbbas_X @IanARowe @BloomPringle @tom_marjot @brennap9 @Drwenhaoli @laura_eburke @BSGTrainees @BASLedu @ScotSocGastro @WAGE_media https://t.co/ANxiTK7XRi
— Oliver Tavabie (@OTavabie) April 5, 2024
We're delighted to launch our @LindAlliance survey which will help define future research priorities for patients with cirrhosis - if your a patient, carer, HCP or work in any capacity with patients with cirrhosis we want to hear from you! @LiverTrust https://t.co/UF0YiLkw8M
— UK_CLIF (@UK_CLIF) May 16, 2024
It was a pleasure to welcome @drgautammehta to speak at @BartsHepatology teaching today! Lots of insightful discussions and collaboratives ideas on alcohol-related liver disease, digital health care for liver patients and @UK_CLIF network pic.twitter.com/ULzyG0kHKd
— Barts Hepatology (@BartsHepatology) May 8, 2024